Panobinostat in Combination With Carfilzomib and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2016

Primary Completion Date

February 28, 2021

Study Completion Date

February 28, 2021

Conditions
Multiple Myeloma
Interventions
DRUG

panobinostat (capsules)

Panobinostat capsules, oral: 10mg, 15mg, 20mg dosing 3x a week, 1 week on / 1 week off, in a 4 week cycle (28 days). Treatment arm A: only capsules of 10mg will be used Treatment arm B: capsules of 10mg and 15mg are foreseen for dose reduction only.

DRUG

carfilzomib (infusion)

Carfilzomib infusion; 20 mg/m2 i.v. on C1D1 and C1D2; 56 mg/m2 i.v. on subsequent dosing days (2x a week; 3 weeks on/1 weeks off ); 4 week cycle (28 days)

DRUG

dexamethasone (tablets)

Dexamethasone tablets p.o. 20 mg on days of carfilzomib infusion (2x week) and on D22 and D23 of each 4 week cycle (28 days)

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY